Cargando…

Newborn screening and gene therapy in SMA: Challenges related to vaccinations

Spinal muscular atrophy (SMA) affects one in 7,500–10,000 newborns. Before the era of disease-modifying therapies, it used to be the major genetic cause of mortality in infants. Currently, there are three therapies approved for SMA, including two molecules modifying the splicing of the SMN2 gene and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kotulska, Katarzyna, Jozwiak, Sergiusz, Jedrzejowska, Maria, Gos, Monika, Ogrodnik, Magdalena, Wysocki, Jacek, Czajka, Hanna, Kuchar, Ernest
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727226/ https://www.ncbi.nlm.nih.gov/pubmed/36504644 http://dx.doi.org/10.3389/fneur.2022.890860

Ejemplares similares

Maintenance Therapy With Everolimus for Subependymal Giant Cell Astrocytoma in Patients With Tuberous Sclerosis – Final Results From the EMINENTS Study
por: Bobeff, Katarzyna, et al.
Publicado: (2021)

Antiepileptic Effect and Safety Profile of Rapamycin in Pediatric Patients With Tuberous Sclerosis Complex
por: Sadowski, Krzysztof, et al.
Publicado: (2022)

Safety of Sirolimus in Patients with Tuberous Sclerosis Complex under Two Years of Age—A Bicenter Retrospective Study
por: Śmiałek, Dominika, et al.
Publicado: (2023)

Editorial: Tuberous Sclerosis Complex – Diagnosis and Management
por: Jozwiak, Sergiusz, et al.
Publicado: (2021)

Effect of mTOR Inhibitors in Epilepsy Treatment in Children with Tuberous Sclerosis Complex Under 2 Years of Age
por: Śmiałek, Dominika, et al.
Publicado: (2023)

Hyperbaric oxygen therapy as an adjunct to corticosteroid treatment in sudden sensorineural hearing loss: a retrospective study
por: Skarzynski, Piotr H., et al.
Publicado: (2023)

Quality of Life in SMA Patients Under Treatment With Nusinersen
por: Mix, Lucas, et al.
Publicado: (2021)

Editorial: Viral vector-based gene therapy in neurological disease: The future is now
por: Smith, Jared B., et al.
Publicado: (2023)

Gene Therapy in ALS and SMA: Advances, Challenges and Perspectives
por: Lejman, Jan, et al.
Publicado: (2023)

Safety, Tolerability, and Effect of Nusinersen Treatment in Ambulatory Adults With 5q-SMA
por: Elsheikh, Bakri, et al.
Publicado: (2021)

One Year of Newborn Screening for SMA – Results of a German Pilot Project
por: Vill, Katharina, et al.
Publicado: (2019)

A call to introduce newborn screening for spinal muscular atrophy (SMA) in Scotland
por: Gillingwater, Thomas H., et al.
Publicado: (2022)

Parental Burden and Quality of Life in 5q-SMA Diagnosed by Newborn Screening
por: Kölbel, Heike, et al.
Publicado: (2022)

Advances in Newborn Screening and Presymptomatic Diagnosis of Spinal Muscular Atrophy
por: Jędrzejowska, Maria
Publicado: (2020)

Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex—Current Views on Their Pathogenesis and Management
por: Gao, Chao, et al.
Publicado: (2023)

Epilepsy in Dravet Syndrome—Current and Future Therapeutic Opportunities
por: Gao, Chao, et al.
Publicado: (2023)

Recombinant Adeno-Associated Virus Serotype 9 Gene Therapy in Spinal Muscular Atrophy
por: Kotulska, Katarzyna, et al.
Publicado: (2021)

Epilepsy and Language Development in 8–36-Month-Old Toddlers with Tuberous Sclerosis Complex
por: Foryś-Basiejko, Małgorzata, et al.
Publicado: (2022)

The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs
por: Hensel, Niko, et al.
Publicado: (2020)

Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With Nusinersen
por: Wurster, Claudia D., et al.
Publicado: (2019)

Effect of the COVID-19 Pandemic on Children With SMA Receiving Nusinersen: What Is Missed and What Is Gained?
por: Agosto, Caterina, et al.
Publicado: (2021)

Prediction of Neurodevelopment in Infants With Tuberous Sclerosis Complex Using Early EEG Characteristics
por: De Ridder, Jessie, et al.
Publicado: (2020)

Congenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex
por: Kotulska, Katarzyna, et al.
Publicado: (2014)

New Insights into Red Blood Cell Microcytosis upon mTOR Inhibitor Administration
por: Jakubowska, Justyna, et al.
Publicado: (2021)

Development of a Multiplex Real-Time PCR Assay for the Newborn Screening of SCID, SMA, and XLA
por: Gutierrez-Mateo, Cristina, et al.
Publicado: (2019)

The Maximum Bite Force for Treatment Evaluation in Severely Affected Adult SMA Patients—Protocol for a Longitudinal Study
por: Kruse, Teresa, et al.
Publicado: (2020)

Early diagnosis of tuberous sclerosis complex: a race against time. How to make the diagnosis before seizures?
por: Słowińska, Monika, et al.
Publicado: (2018)

MicroRNA Expression Profile in TSC Cell Lines and the Impact of mTOR Inhibitor
por: Pawlik, Bartłomiej, et al.
Publicado: (2022)

Newborn screening for X-linked adrenoleukodystrophy in Italy: Diagnostic algorithm and disease monitoring
por: Bonaventura, Eleonora, et al.
Publicado: (2023)

Biochemical Screening of Intellectually Disabled Patients: A Stepping Stone to Initiate a Newborn Screening Program in Pakistan
por: Wasim, Muhammad, et al.
Publicado: (2019)

Hearing Screening among First-Grade Children in Rural Areas and Small Towns in Małopolskie Voivodeship, Poland
por: Swierniak, Weronika, et al.
Publicado: (2021)

Abnormal serum microRNA profiles in tuberous sclerosis are normalized during treatment with everolimus: possible clinical implications
por: Trelinska, Joanna, et al.
Publicado: (2016)

Addressing the implementation gap in advanced therapeutics for spinal muscular atrophy in the era of newborn screening programs
por: Leon-Astudillo, Carmen, et al.
Publicado: (2022)

SMA Identified: Clinical and Molecular Findings From a Sponsored Testing Program for Spinal Muscular Atrophy in More Than 2,000 Individuals
por: Bowen, B. Monica, et al.
Publicado: (2021)

Parents and Caregivers Satisfaction After Palliative Treatment of Spastic Hip Dislocation in Cerebral Palsy
por: Koch, Aleksander, et al.
Publicado: (2021)

“I have SMA, SMA doesn’t have me”: a qualitative snapshot into the challenges, successes, and quality of life of adolescents and young adults with SMA
por: Mazzella, Allison, et al.
Publicado: (2021)

Vestibular Function After Cochlear Implantation in Partial Deafness Treatment
por: Sosna-Duranowska, Magdalena, et al.
Publicado: (2021)

Results of Hearing Screening in School-Age Children from Rural Areas of the Kujawsko–Pomorskie Region in Poland
por: Gos, Elzbieta, et al.
Publicado: (2022)

Cervical dystonia and no oculomotor apraxia as new manifestation of ataxia-telangiectasia-like disorder 1 – case report and review of the literature
por: Bajek, Agnieszka, et al.
Publicado: (2023)

mTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Is Associated with Specific Changes in microRNA Serum Profile
por: Pawlik, Bartłomiej, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_51ipm91cba2uu6m7r3g5pcm17d